Needleman; Philip

Patent Applications and Registrations

Patent applications and USPTO patent grants for Needleman; Philip.The latest application filed is for "method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders".

Company Profile

0.3.11

Needleman; Philip - Creve Coeur MO
Needleman; Philip - Olivette MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders App 20070072861 - Roniker; Barbara ; et al.	2007-03-29
Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders App 20050107387 - Needleman, Philip ; et al.	2005-05-19
Treatment of Alzheimer's disease with the R(-) isomer of a 2-arylpropionic acid non-steroidal anti-inflammatory drug alone or in combination with a cyclooxygenase-2 selective inhibitor App 20050004224 - Needleman, Philip	2005-01-06
Method of using cyclooxegenase-2 inhibitors in the treatment and prevention of dementia App 20040242667 - Needleman, Philip	2004-12-02
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors App 20030220374 - Needleman, Philip	2003-11-27
Combination therapy for the treatment of bacterial infections App 20030191051 - Needleman, Philip ; et al.	2003-10-09
Immunological Process And Constructs For Increasing The Hdl Cholesterol Concentration By Dna Vaccination App 20030100520 - NEEDLEMAN, PHILIP ; et al.	2003-05-29
An IMMUNOLOGICAL PROCESS FOR INCREASING THE HDL CHOLESTROL CONCENTRATION App 20030026808 - NEEDLEMAN, PHILIP ; et al.	2003-02-06
Immunological Process For Increasing The Hdl Cholestrol Concentration App 20030021804 - NEEDLEMAN, PHILIP ; et al.	2003-01-30
Method of using cyclooxegenase-2 inhibitors in the treatment and prevention of dementia App 20020058688 - Needleman, Philip	2002-05-16
Combination therapy in the prevention of cardiovascular disorders App 20020035156 - Roniker, Barbara ; et al.	2002-03-21
Atrial peptides Grant 4,557,864 - Needleman December 10, 1	1985-12-10
Atrial peptide Grant 4,508,712 - Needleman April 2, 1	1985-04-02
Atrial Peptides Grant 4,496,544 - Needleman January 29, 1	1985-01-29

Company Registrations

SEC

0001083221

NEEDLEMAN PHILIP

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.